勃起不全デバイスの世界市場：洞察、競合情勢、市場予測：2030年

勃起不全デバイスの市場規模は、2023年に17億7,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.81％のCAGRで拡大し、2030年には33億9,000万米ドルに達すると予測されています。勃起不全（ED）デバイス市場は、特に心血管疾患（CVD）や糖尿病などの慢性疾患を持つ患者の間で勃起不全の有病率が上昇しており、EDの発症リスクが高まっていることから、大幅な成長が予測されています。勃起不全はあらゆる年齢の男性に影響を及ぼす可能性がありますが、糖尿病、高血圧、前立腺がん、不安、うつ病などの基礎的な健康問題をしばしば抱える高齢男性に特に多く見られます。さらに、高齢男性人口の増加、肥満の急増、喫煙や運動不足などの座りがちなライフスタイル要因などが、2024年から2030年までの予測期間中にEDデバイス市場の成長を促進すると予想される主な要因です。

勃起不全（ED）デバイス市場は、男性のED有病率の上昇に牽引され、大きな成長を遂げています。世界保健機関（WHO）によると、2025年までに全世界で推定3億2,000万人の男性が勃起不全に罹患し、効果的な治療に対するニーズが高まっています。ペニスの機能を回復させるように設計されたEDデバイスは、ED患者の数が増加し続けていることから、人気を集めています。

EDデバイス市場の成長に寄与する重要な要因の1つは、高血圧や冠動脈疾患などの心臓疾患と勃起不全との関連性です。勃起には十分な血流が不可欠であるため、血液循環を損なう心血管系の問題はEDにつながる可能性があります。2023年のWHOの報告書では、30～79歳の12億8,000万人が、血流を乱し勃起不全の可能性を高める高血圧症を抱えて生活していると推定されています。心臓病の罹患率が世界的に上昇するにつれて、EDの罹患率も上昇し、EDデバイスの需要に拍車をかけています。

当レポートでは、世界の勃起不全デバイス市場について調査し、市場の概要とともに、製品別、アプローチ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 勃起不全デバイス市場レポートのイントロダクション

第2章 勃起不全デバイス市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 勃起不全デバイス市場の主な要因分析

• 勃起不全デバイスの市場促進要因
• 勃起不全デバイスの市場抑制要因と課題
• 勃起不全デバイスの市場機会

第6章 勃起不全デバイス市場におけるポーターのファイブフォース分析

第7章 勃起不全デバイス市場の評価

• 製品別
• アプローチ別
• エンドユーザー別
• 地域別

第8章 勃起不全デバイス市場の企業と製品の概要

• Coloplast Group
• Zimmer Aesthetics
• Augusta Medical Systems
• MediSpec
• MTS Medical
• Boston Scientific Corporation
• NOVAmedtek
• Promedon GmbH
• Global Life Technologies LLC
• Zephyr Surgical Implants
• Owen Mumford
• Vacurect
• T.E. Inc.
• SILIMED
• STORZ MEDICAL AG
• Rigicon, Inc.
• TIMM Medical
• Alma Lasers
• Comphya SA
• Ohh-Med Medical Ltd.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Erectile Dysfunction Devices Market in Global (2021-2030)
• Table 3: Erectile Dysfunction Devices Market in Global by Product (2021-2030)
• Table 4: Erectile Dysfunction Devices Market in Global by Approach (2021-2030)
• Table 5: Erectile Dysfunction Devices Market in Global by End-User (2021-2030)
• Table 6: Erectile Dysfunction Devices Market in Global by Geography (2021-2030)
• Table 7: Erectile Dysfunction Devices Market in North America (2021-2030)
• Table 8: Erectile Dysfunction Devices Market in the United States (2021-2030)
• Table 9: Erectile Dysfunction Devices Market in Canada (2021-2030)
• Table 10: Erectile Dysfunction Devices Market in Mexico (2021-2030)
• Table 11: Erectile Dysfunction Devices Market in Europe (2021-2030)
• Table 12: Erectile Dysfunction Devices Market in France (2021-2030)
• Table 13: Erectile Dysfunction Devices Market in Germany (2021-2030)
• Table 14: Erectile Dysfunction Devices Market in United Kingdom (2021-2030)
• Table 15: Erectile Dysfunction Devices Market in Italy (2021-2030)
• Table 16: Erectile Dysfunction Devices Market in Spain (2021-2030)
• Table 17: Erectile Dysfunction Devices Market in the Rest of Europe (2021-2030)
• Table 18: Erectile Dysfunction Devices Market in Asia-Pacific (2021-2030)
• Table 19: Erectile Dysfunction Devices Market in China (2021-2030)
• Table 20: Erectile Dysfunction Devices Market in Japan (2021-2030)
• Table 21: Erectile Dysfunction Devices Market in India (2021-2030)
• Table 22: Erectile Dysfunction Devices Market in Australia (2021-2030)
• Table 23: Erectile Dysfunction Devices Market in South Korea (2021-2030)
• Table 24: Erectile Dysfunction Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Erectile Dysfunction Devices Market in the Rest of the World (2021-2030)
• Table 26: Erectile Dysfunction Devices Market in the Middle East (2021-2030)
• Table 27: Erectile Dysfunction Devices Market in Africa (2021-2030)
• Table 28: Erectile Dysfunction Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Erectile Dysfunction Devices Market in Global (2021-2030)
• Figure 3: Erectile Dysfunction Devices Market in Global by Product (2021-2030)
• Figure 4: Erectile Dysfunction Devices Market in Global by Approach (2021-2030)
• Figure 5: Erectile Dysfunction Devices Market in Global by End-User (2021-2030)
• Figure 6: Erectile Dysfunction Devices Market in Global by Geography (2021-2030)
• Figure 7: Erectile Dysfunction Devices Market in North America (2021-2030)
• Figure 8: Erectile Dysfunction Devices Market in the United States (2021-2030)
• Figure 9: Erectile Dysfunction Devices Market in Canada (2021-2030)
• Figure 10: Erectile Dysfunction Devices Market in Mexico (2021-2030)
• Figure 11: Erectile Dysfunction Devices Market in Europe (2021-2030)
• Figure 12: Erectile Dysfunction Devices Market in France (2021-2030)
• Figure 13: Erectile Dysfunction Devices Market in Germany (2021-2030)
• Figure 14: Erectile Dysfunction Devices Market in United Kingdom (2021-2030)
• Figure 15: Erectile Dysfunction Devices Market in Italy (2021-2030)
• Figure 16: Erectile Dysfunction Devices Market in Spain (2021-2030)
• Figure 17: Erectile Dysfunction Devices Market in the Rest of Europe (2021-2030)
• Figure 18: Erectile Dysfunction Devices Market in Asia-Pacific (2021-2030)
• Figure 19: Erectile Dysfunction Devices Market in China (2021-2030)
• Figure 20: Erectile Dysfunction Devices Market in Japan (2021-2030)
• Figure 21: Erectile Dysfunction Devices Market in India (2021-2030)
• Figure 22: Erectile Dysfunction Devices Market in Australia (2021-2030)
• Figure 23: Erectile Dysfunction Devices Market in South Korea (2021-2030)
• Figure 24: Erectile Dysfunction Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Erectile Dysfunction Devices Market in the Rest of the World (2021-2030)
• Figure 26: Erectile Dysfunction Devices Market in the Middle East (2021-2030)
• Figure 27: Erectile Dysfunction Devices Market in Africa (2021-2030)
• Figure 28: Erectile Dysfunction Devices Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Erectile Dysfunction Devices Market by Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, and Others), Approach (Invasive, Non-Invasive), End-User (Hospitals and Clinics, Ambulatory Surgical Centers (ASC), and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to growing prevalence of erectile dysfunction and increase in geriatric population of men.

The erectile dysfunction devices market was valued at USD 1.77 billion in 2023, growing at a CAGR of 9.81% during the forecast period from 2024 to 2030, to reach USD 3.39 billion by 2030. The erectile dysfunction (ED) devices market is projected to experience substantial growth due to the increasing prevalence of erectile dysfunction, particularly among patients with chronic conditions such as cardiovascular disease (CVD) and diabetes, which heighten the risk of developing ED. While erectile dysfunction can affect men of all ages, it is especially common among older men who often contend with underlying health issues like diabetes, hypertension, prostate cancer, anxiety, and depression. Additionally, the rising geriatric male population, along with a surge in obesity and sedentary lifestyle factors such as smoking and lack of exercise, are key drivers expected to fuel the growth of the ED devices market during the forecast period from 2024 to 2030.

Erectile Dysfunction Devices Market Dynamics:

The erectile dysfunction (ED) devices market has witnessed significant growth, driven by the rising prevalence of ED among men. According to the World Health Organization (WHO), by 2025, an estimated 320 million men worldwide will be affected by erectile dysfunction, underscoring the growing need for effective treatments. ED devices, designed to restore penile function, are gaining traction as the number of ED cases continues to rise.

One key factor contributing to the growth of the ED devices market is the link between heart diseases, such as hypertension and coronary artery disease, and erectile dysfunction. Since adequate blood flow is essential for an erection, cardiovascular issues that impair blood circulation can lead to ED. In a 2023 WHO report, it was estimated that 1.28 billion people aged 30-79 years were living with hypertension, a condition that disrupts blood flow and can increase the likelihood of erectile dysfunction. As heart disease rates rise globally, so does the incidence of ED, fueling the demand for ED devices.

Diabetes is another major risk factor for erectile dysfunction. Men with diabetes, especially those with poorly controlled blood sugar levels, are at a significantly higher risk of developing ED. According to the Centers for Disease Control and Prevention (CDC) in May 2024, men with diabetes are three times more likely to suffer from ED. The International Diabetes Federation reported that 537 million adults worldwide were living with diabetes in 2021, and this number is projected to rise to 643 million by 2030 and 783 million by 2045. This surge in diabetes cases will likely drive further growth in the ED devices market.

Other risk factors such as smoking and obesity also contribute to the increasing prevalence of ED. The CDC identified smoking as a leading cause of erectile dysfunction in men in the U.S. As of May 2024, the CDC also noted that while aging does not directly cause ED, it significantly increases the likelihood of developing the condition. The global male population, which was 4 billion in 2022, grew to 4.03 billion in 2023, with a large portion being older men, further boosting the demand for ED treatment devices.

Despite these growth drivers, the ED devices market faces challenges. The high cost of advanced and invasive devices, potential device malfunctions, and the complexity of certain treatment options are some of the key constraints that could limit market expansion.

Overall, the increasing prevalence of erectile dysfunction, driven by heart disease, diabetes, aging, smoking, and obesity, is propelling the growth of the ED devices market. However, overcoming the associated challenges will be critical to sustaining this momentum in the coming years.

Erectile Dysfunction Devices Market Segment Analysis:

Erectile Dysfunction Devices Market by Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, Others), Approach (Invasive, Non-Invasive), End-User (Hospitals and Clinics, Ambulatory Surgical Centers (ASC), Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the erectile dysfunction devices market, the vacuum therapy devices segment is expected to dominate, capturing a significant share of the market. This growth is driven by several key factors, including the widespread adoption of vacuum therapy devices, their cost-effectiveness, and the numerous benefits they offer to users.

Vacuum therapy devices are designed to produce an erection suitable for sexual intercourse without the need for medications, injections, or surgery, making them a highly effective treatment option for erectile dysfunction. These devices boast multiple advantages, such as ease of use and the ability to induce an erection in just 2 to 3 minutes, allowing for greater spontaneity. Additionally, they offer a reliable, non-invasive solution, making them an attractive choice for men seeking effective ED management without the risks or recovery time associated with more invasive procedures.

The non-invasive nature of vacuum therapy devices eliminates the need for surgery or medication, further enhancing their appeal. These devices are proven to be effective for many men in achieving and maintaining erections, positioning them as a valuable option in the broader treatment landscape for erectile dysfunction.

Given these advantages-ease of use, rapid results, non-invasiveness, and cost-effectiveness-the vacuum therapy devices segment is expected to drive the overall growth of the erectile dysfunction devices market throughout the forecast period.

North America is expected to dominate the overall erectile dysfunction devices market:

North America is poised to lead the global erectile dysfunction (ED) devices market during the forecast period, with the United States playing a key role. This dominance is largely driven by the increasing prevalence of erectile dysfunction across the region, heightened awareness about the condition, and an upsurge in related risk factors such as prostate cancer and diabetes. Furthermore, product innovations, approvals, and launches continue to bolster the market's growth.

According to the Centers for Disease Control and Prevention (CDC), approximately 30 million adults in the U.S. were affected by erectile dysfunction in 2021, with middle-aged and older men being the most impacted. In addition, the CDC reported in June 2024 that there were 236,659 new cases of prostate cancer in the U.S. in 2021, with the American Cancer Society projecting 299,010 new cases in 2024. Since prostate cancer treatments often result in erectile dysfunction as a side effect, the growing prevalence of prostate cancer is expected to significantly contribute to the expansion of the ED devices market.

Key players in North America are focusing on advancing technology and developing innovative solutions to address ED. A notable example is the introduction of Alma Duo by Alma Lasers in January 2021 in the U.S. This device utilizes focused low-intensity extracorporeal shock wave therapy (LI-ESWT) to treat erectile dysfunction, offering a non-invasive option for men.

With the increasing prevalence of erectile dysfunction, rising awareness, and continued research and development by industry leaders, North America's erectile dysfunction devices market is anticipated to experience substantial growth in the coming years.

Therefore, the rising prevalence of erectile dysfunction and its contributing risk factors and R&D activities by key players are expected to propel the positive growth of the erectile dysfunction devices market in North America.

Erectile Dysfunction Devices Market Key Players:

Some of the key market players operating in the erectile dysfunction devices market include Coloplast Group, Zimmer Aesthetics, Augusta Medical Systems, Medispec, MTS Medical, Boston Scientific Corporation, NOVAmedtek, Promedon GmbH, Global Life Technologies LLC, Zephyr Surgical Implants, Owen Mumford, Vacurect, T.E. Inc., SILIMED, STORZ MEDICAL AG, Rigicon, Inc., TIMM Medical, Alma Lasers, Comphya SA, Ohh-Med Medical Ltd., and others.

Recent Developmental Activities in the Erectile Dysfunction Devices Market:

• In June 2024, Ohh-Med Medical Ltd. launched VerticaPlus with a cloud-based mobile app. Vertica is a pioneering medical device designed to enhance erection quality over time by targeting the Tunica Albuginea in the penis, thereby reducing leakage and outflow. This innovative approach optimizes the natural erectile mechanism without relying on medication, allowing for complete spontaneity in intimate relations and eliminating associated side effects.
• In June 2023, Rigicon, Inc. launched the HL-LEVINE penile prosthesis tool. This prosthesis tool integrates the HL dilator with the traditional Furlow instrument, both of which are utilized in penile implant surgery. It streamlines the dilation and insertion process of penile implants, thereby reducing the risk of surgical complications and enhancing postoperative outcomes.
• In January 2021, Giddy launched Eddie, a first-of-its-kind, wearable, FDA Class II erectile dysfunction device, which works with the natural physiology of an erection.

Key Takeaways from the Erectile Dysfunction Devices Market Report Study

• Market size analysis for current Erectile Dysfunction Devices Market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Erectile Dysfunction Devices market.
• Various opportunities are available for the other competitors in the Erectile Dysfunction Devices Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Erectile Dysfunction Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Erectile Dysfunction Devices market growth in the coming future?

Target Audience who can be benefited from this Erectile Dysfunction Devices Market Report Study

• Erectile Dysfunction Devices product providers
• Research organizations and consulting companies
• Erectile Dysfunction Devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Erectile Dysfunction Devices
• Various end-users who want to know more about the Erectile Dysfunction Devices Market and the latest technological developments in the Erectile Dysfunction Devices Market.

Frequently Asked Questions for the Erectile Dysfunction Devices Market:

1. What are Erectile Dysfunction Devices?

• Erectile dysfunction devices refer to medical devices that pump blood through the penis for an erection to take place, allowing it to extend and stiffen, which is sparked by stimuli from the brain to the genital nerves. When these impulses are blocked or the supply of blood to the penis is reduced, Erectile Dysfunction Devices are used to treat the patient and restore normal functioning.

2. What is the market for Erectile Dysfunction Devices?

• The erectile dysfunction devices market was valued at USD 1.77 billion in 2023, growing at a CAGR of 9.81% during the forecast period from 2024 to 2030, to reach USD 3.39 billion by 2030.

3. What are the drivers for the Erectile Dysfunction Devices market?

• The erectile dysfunction (ED) devices market is projected to experience substantial growth due to the increasing prevalence of erectile dysfunction, particularly among patients with chronic conditions such as cardiovascular disease (CVD) and diabetes, which heighten the risk of developing ED. While erectile dysfunction can affect men of all ages, it is especially common among older men who often contend with underlying health issues like diabetes, hypertension, prostate cancer, anxiety, and depression. Additionally, the rising geriatric male population, along with a surge in obesity and sedentary lifestyle factors such as smoking and lack of exercise, are key drivers expected to fuel the growth of the ED devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Erectile Dysfunction Devices market?

• Some of the key market players operating in the erectile dysfunction devices market include Coloplast Group, Zimmer Aesthetics, Augusta Medical Systems, Medispec, MTS Medical, Boston Scientific Corporation, NOVAmedtek, Promedon GmbH, Global Life Technologies LLC, Zephyr Surgical Implants, Owen Mumford, Vacurect, T.E. Inc., SILIMED, STORZ MEDICAL AG, Rigicon, Inc., TIMM Medical, Alma Lasers, Comphya SA, Ohh-Med Medical Ltd., and others.

5. Which region has the highest share in the Erectile Dysfunction Devices market?

• North America is poised to lead the global erectile dysfunction (ED) devices market during the forecast period, with the United States playing a key role. This dominance is largely driven by the increasing prevalence of erectile dysfunction across the region, heightened awareness about the condition, and an upsurge in related risk factors such as prostate cancer and diabetes. Furthermore, product innovations, approvals, and launches continue to bolster the market's growth.

Table of Contents

1. Erectile Dysfunction Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Erectile Dysfunction Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Erectile Dysfunction Devices Market Key Factors Analysis

• 5.1. Erectile Dysfunction Devices Market Drivers
  • 5.1.1. The growing prevalence of erectile dysfunction
  • 5.1.2. Rise in the number of patients suffering from chronic disease
  • 5.1.3. An increase in the geriatric population of men
• 5.2. Erectile Dysfunction Devices Market Restraints and Challenges
  • 5.2.1. High cost of advanced and invasive devices
  • 5.2.2. Complexity and chances of device malfunctioning
• 5.3. Erectile Dysfunction Devices Market Opportunity
  • 5.3.1. Integration of robotic implantation and digital health for therapies
  • 5.3.2. Adoption of these advanced devices in developing countries

6. Erectile Dysfunction Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Erectile Dysfunction Devices Market Assessment

• 7.1. By Product
  • 7.1.1. Penile Implants
  • 7.1.2. Shockwave Therapy Devices
  • 7.1.3. Vacuum Therapy Devices
  • 7.1.4. Others
• 7.2. By Approach
  • 7.2.1. Invasive
  • 7.2.2. Non-Invasive
• 7.3. By End-User
  • 7.3.1. Hospitals and Clinics
  • 7.3.2. Ambulatory Surgical Centers (ASCs)
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Erectile Dysfunction Devices Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Erectile Dysfunction Devices Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.3.3. India Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Erectile Dysfunction Devices Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Erectile Dysfunction Devices Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Erectile Dysfunction Devices Market Size In USD Million (2021-2030)

8. Erectile Dysfunction Devices Market Company and Product Profiles

• 8.1. Coloplast Group
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Zimmer Aesthetics
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Augusta Medical Systems
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. MediSpec
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. MTS Medical
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Boston Scientific Corporation
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. NOVAmedtek
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Promedon GmbH
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Global Life Technologies LLC
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Zephyr Surgical Implants
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Owen Mumford
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Vacurect
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. T.E. Inc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. SILIMED
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. STORZ MEDICAL AG
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Rigicon, Inc.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. TIMM Medical
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Alma Lasers
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Comphya SA
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Ohh-Med Medical Ltd.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us